• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

库欣综合征中的葡萄糖代谢异常:从分子基础到临床管理。

Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management.

机构信息

Endocrinology Unit, Department of Medicine, DIMED, University of Padova, Via Ospedale 105, 35128 Padua, Italy.

Department of Cell Physiology & Metabolism, Centre Médical Universitaire, 1 Rue Michel Servet, 1211 Genèva, Switzerland.

出版信息

Endocr Rev. 2017 Jun 1;38(3):189-219. doi: 10.1210/er.2016-1105.

DOI:10.1210/er.2016-1105
PMID:28368467
Abstract

An impaired glucose metabolism, which often leads to the onset of diabetes mellitus (DM), is a common complication of chronic exposure to exogenous and endogenous glucocorticoid (GC) excess and plays an important part in contributing to morbidity and mortality in patients with Cushing syndrome (CS). This article reviews the pathogenesis, epidemiology, diagnosis, and management of changes in glucose metabolism associated with hypercortisolism, addressing both the pathophysiological aspects and the clinical and therapeutic implications. Chronic hypercortisolism may have pleiotropic effects on all major peripheral tissues governing glucose homeostasis. Adding further complexity, both genomic and nongenomic mechanisms are directly induced by GCs in a context-specific and cell-/organ-dependent manner. In this paper, the discussion focuses on established and potential pathologic molecular mechanisms that are induced by chronically excessive circulating levels of GCs and affect glucose homeostasis in various tissues. The management of patients with CS and DM includes treating their hyperglycemia and correcting their GC excess. The effects on glycemic control of various medical therapies for CS are reviewed in this paper. The association between DM and subclinical CS and the role of screening for CS in diabetic patients are also discussed.

摘要

葡萄糖代谢受损,常导致糖尿病(DM)的发生,是慢性暴露于外源性和内源性糖皮质激素(GC)过多的常见并发症,在库欣综合征(CS)患者的发病率和死亡率中起着重要作用。本文综述了与皮质醇过多相关的葡萄糖代谢变化的发病机制、流行病学、诊断和管理,涉及病理生理方面以及临床和治疗意义。慢性高皮质醇血症可能对所有控制葡萄糖稳态的主要外周组织具有多效性影响。此外,基因组和非基因组机制都可以通过 GC 以特定于上下文和细胞/组织依赖性的方式直接诱导。本文的讨论重点是由循环中 GC 水平长期过度引起的、影响各种组织葡萄糖稳态的已确立和潜在的病理性分子机制。CS 和 DM 患者的管理包括治疗其高血糖和纠正 GC 过多。本文还回顾了各种 CS 治疗方法对血糖控制的影响。本文还讨论了 DM 与亚临床 CS 的关系以及在糖尿病患者中筛查 CS 的作用。

相似文献

1
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management.库欣综合征中的葡萄糖代谢异常:从分子基础到临床管理。
Endocr Rev. 2017 Jun 1;38(3):189-219. doi: 10.1210/er.2016-1105.
2
Diabetes in Cushing syndrome: basic and clinical aspects.库欣综合征中的糖尿病:基础与临床方面。
Trends Endocrinol Metab. 2011 Dec;22(12):499-506. doi: 10.1016/j.tem.2011.09.001. Epub 2011 Oct 11.
3
Expression of selected angiogenesis-related small microRNAs in patients with abnormally increased secretion of glucocorticoids.异常增加糖皮质激素分泌患者中选定的血管生成相关小 microRNAs 的表达。
Endokrynol Pol. 2019;70(6):489-495. doi: 10.5603/EP.a2019.0061.
4
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.与主要内分泌疾病相关的继发性糖尿病:新治疗模式的影响
Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26.
5
Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.内分泌紊乱与外周动脉疾病 - 系列综述 库欣综合征 - 皮质醇过多症。
Curr Vasc Pharmacol. 2024;22(4):236-241. doi: 10.2174/0115701611272145231106053914.
6
Metabolic comorbidities in Cushing's syndrome.库欣综合征中的代谢合并症。
Eur J Endocrinol. 2015 Oct;173(4):M133-57. doi: 10.1530/EJE-15-0354. Epub 2015 Jun 9.
7
Glucose and lipid metabolism abnormalities in Cushing's syndrome.库欣综合征中的糖脂代谢异常。
J Neuroendocrinol. 2022 Aug;34(8):e13143. doi: 10.1111/jne.13143. Epub 2022 Aug 18.
8
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising Model to Study Cushing's Syndrome.间质干细胞暴露于持续高水平的糖皮质激素下会产生胰岛素抵抗和脂解改变:研究库欣综合征的有前途模型。
Front Endocrinol (Lausanne). 2022 Feb 24;13:816229. doi: 10.3389/fendo.2022.816229. eCollection 2022.
9
[Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].[评估不同内源性皮质醇水平人群血浆中瘦素水平及其对影响组织脂肪水平的其他激素因素的依赖性]
Ann Acad Med Stetin. 2002;48:283-300.
10
[Carbohydrate metabolism in glucocorticoid excess].[糖皮质激素过多时的碳水化合物代谢]
Nihon Rinsho. 2002 Jul;60 Suppl 7:703-8.

引用本文的文献

1
Dose-dependent and tissue-specific adverse effects of exogenous glucocorticoids: insights for optimizing clinical practice.外源性糖皮质激素的剂量依赖性和组织特异性不良反应:优化临床实践的见解
J Endocrinol Invest. 2025 Jul 7. doi: 10.1007/s40618-025-02637-x.
2
Sex-dependent effects of FGF21 on HPA axis regulation and adrenal regeneration after Cushing syndrome in mice.成纤维细胞生长因子21对小鼠库欣综合征后下丘脑-垂体-肾上腺轴调节及肾上腺再生的性别依赖性影响。
Mol Metab. 2025 Jun;96:102122. doi: 10.1016/j.molmet.2025.102122. Epub 2025 Mar 26.
3
Nomogram for predicting postoperative clinical remission of hypertension in patients with adrenal tumors.
预测肾上腺肿瘤患者术后高血压临床缓解的列线图
Discov Oncol. 2025 Mar 17;16(1):341. doi: 10.1007/s12672-025-02108-y.
4
Continuum of glucose and bone metabolism impairment across autonomous cortisol secretion: A cross-sectional study.自主皮质醇分泌过程中葡萄糖和骨代谢损害的连续体:一项横断面研究。
World J Diabetes. 2025 Mar 15;16(3):100580. doi: 10.4239/wjd.v16.i3.100580.
5
Quercetin and Catechin Protects Leptin-Deficient Lep Mice Against Alloxan-Induced Diabetes and Hepatotoxicity via Suppression of Oxidative Stress and Inflammation.槲皮素和儿茶素通过抑制氧化应激和炎症反应,保护瘦素缺乏的Lep小鼠免受四氧嘧啶诱导的糖尿病和肝毒性。
Rep Biochem Mol Biol. 2024 Jul;13(2):184-195. doi: 10.61186/rbmb.13.2.184.
6
Serum Cortisol and Cardiovascular Disease Risk - A Potential Biomarker.血清皮质醇与心血管疾病风险——一种潜在的生物标志物。
Curr Cardiol Rev. 2025;21(3):e1573403X328499. doi: 10.2174/011573403X328499241106064553.
7
Pasireotide-induced hyperglycemia in Cushing's disease and Acromegaly: A clinical perspective and algorithms proposal.帕西瑞肽诱发库欣病和肢端肥大症患者高血糖:临床视角及算法建议
Front Endocrinol (Lausanne). 2024 Dec 13;15:1455465. doi: 10.3389/fendo.2024.1455465. eCollection 2024.
8
Cushing's syndrome and COVID-19.库欣综合征与新型冠状病毒肺炎
Pituitary. 2024 Dec;27(6):945-954. doi: 10.1007/s11102-024-01466-0. Epub 2024 Nov 14.
9
Neurobiological Implications of Chronic Stress and Metabolic Dysregulation in Inflammatory Bowel Diseases.慢性应激与代谢失调在炎症性肠病中的神经生物学影响
Diseases. 2024 Sep 18;12(9):220. doi: 10.3390/diseases12090220.
10
Management of Diabetes Mellitus in Acromegaly and Cushing's Disease with Focus on Pasireotide Therapy: A Narrative Review.肢端肥大症和库欣病中糖尿病的管理:聚焦帕西瑞肽治疗的叙述性综述
Diabetes Metab Syndr Obes. 2024 Jul 23;17:2761-2774. doi: 10.2147/DMSO.S466328. eCollection 2024.